Chugai Pharmaceutical Co., Ltd.
Stock Forecast, Prediction & Price Target
Chugai Pharmaceutical Co., Ltd. Financial Estimates
Chugai Pharmaceutical Co., Ltd. Revenue Estimates
Chugai Pharmaceutical Co., Ltd. EBITDA Estimates
Chugai Pharmaceutical Co., Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $999.75B N/A | $1.25T 26.02% | $1.11T -11.79% | Avg: $1.12T Low: $1.12T High: $1.12T avg. 1.64% | |||
Net Income
% change YoY
| $302.99B N/A | $374.42B 23.57% | $325.47B -13.07% | Avg: $179.33B Low: $179.33B High: $179.33B avg. -44.90% | |||
EBITDA
% change YoY
| $419.43B N/A | $531.22B 26.65% | $443.84B -16.44% | Avg: $435.09B Low: $435.09B High: $435.09B avg. -1.97% | |||
EPS
% change YoY
| $184.29 N/A | $227.64 23.52% | $197.8 -13.10% | Avg: $108.98 Low: $108.98 High: $108.98 avg. -44.90% | |||
Operating Expenses
% change YoY
| $239.71B N/A | $250.38B 4.45% | $258.88B 3.39% | Avg: $124.63B Low: $124.63B High: $124.63B avg. -51.85% | |||
FAQ
What is Chugai Pharmaceutical Co., Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -44.90% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is 179.33B, average is 179.33B and high is 179.33B.
What is Chugai Pharmaceutical Co., Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1.64% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $1.12T, average is $1.12T and high is $1.12T.
What is Chugai Pharmaceutical Co., Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -44.90% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is $108.98, average is $108.98 and high is $108.98.